Purchase Order 75N93025P00682

This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a renewal service agreement to support two Illumina NextSeq sequencing systems. The contract has a ceiling value of $74,756.41 and a period of performance through March 20, 2026. There is no set-aside designation for this award. Illumina is a manufacturer of genomic sequencing instruments and reagents that has previously received prime and subcontract awards from NIAID and other federal agencies to support genomic research and diagnostics. This contract award continues Illumina's support for NIAID's nucleic acid sequencing capabilities through the provision of maintenance and service for their existing NextSeq instruments.